Cite
HARVARD Citation
Vaishampayan, U. et al. (n.d.). 803PRandomized trial of androgen deprivation therapy (ADT) + enzalutamide (Arm A) versus ADT + bicalutamide (Arm B) in metastatic hormone sensitive prostate cancer (mHSPC). Annals of oncology. p. . [Online].